Agenus Inc.
(NASDAQ : AGEN)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
BIIBBiogen Inc.
-0.67%342.921.2%$619.87m
GILDGilead Sciences, Inc.
-0.60%72.480.9%$507.63m
CELGCelgene Corporation
-0.40%90.011.2%$494.43m
AMGNAmgen Inc.
-0.06%197.311.2%$485.07m
ILMNIllumina, Inc.
0.28%326.793.5%$374.74m
REGNRegeneron Pharmaceuticals, Inc.
-0.41%372.742.6%$314.50m
VRTXVertex Pharmaceuticals Incorporated
-0.90%174.501.9%$207.20m
ALXNAlexion Pharmaceuticals, Inc.
0.26%116.302.0%$187.07m
AAgilent Technologies, Inc.
0.11%64.731.5%$159.45m
SRPTSarepta Therapeutics, Inc.
-0.26%129.9116.6%$142.09m
NKTRNektar Therapeutics
0.45%60.305.6%$126.86m
BLUEBluebird Bio, Inc.
-0.60%157.0514.6%$120.84m
EXASExact Sciences Corporation
-0.72%48.4925.3%$117.97m
BMRNBioMarin Pharmaceutical Inc.
-2.07%98.924.4%$116.29m
INCYIncyte Corporation
-0.26%68.622.5%$111.44m

Company Profile

Agenus, Inc. is a clinical-stage immuno-oncology company, which engages in the development and commercialization of technologies to treat cancers and infectious diseases. Its product pipeline includes AGEN1884, Next-gen CTLA-A, AGEN2034, INCAGN1876, INCAGN1949, Prophage, AutoSynVax, PhosphoSynVax, and AS-21 Stimulon. The company was founded by Garo H. Armen and Pramod K. Srivastava in March 1994 and is headquartered in Lexington, MA.